Sandrine Künzel, Carl Zeiss MediTec (F), CenterVue (F), Heidelberg Engineering (F), Optos (F);
Maximilian Pfau, Carl Zeiss MediTec (F), CenterVue (F), Heidelberg Engineering (F), Novartis (F), Optos (F);
Moritz Lindner, Carl Zeiss MediTec (F), CenterVue (F), Heidelberg Engineering (F), Optos (F);
Joanna Czauderna, Carl Zeiss MediTec (F), CenterVue (F), Heidelberg Engineering (F), Optos (F);
Philipp Möller, Carl Zeiss MediTec (F), CenterVue (F), Heidelberg Engineering (F), Optos (F);
Leon von der Emde, Carl Zeiss MediTec (F), CenterVue (F), Heidelberg Engineering (F), Optos (F);
Jennifer Nadal, Bayer Healthcare (C), Galimedix (C);
Matthias Schmid, Bayer Healthcare (C), Galimedix (C);
Steffen Schmitz-Valckenberg, Acucela (F), Alcon/Novartis (C), Alcon/Novartis (F), Alcon/Novartis (R), Allergan (F), Allergan (R), Bayer Healthcare (F), Bayer Healthcare (R), Bioeq/Formycon (F), Bioeq/Formycon (C), Carl Zeiss Meditec (F), Carl Zeiss Meditec (R), CenterVue (F), Formycon (F), Galimedix (C), Genentech/Roche (F), Genentech/Roche (R), Heidelberg Engineering (F), Katairo (F), Optos (F);
Frank Holz, Acucela (F), Acucela (C), Allergan (F), Appelis (C), Bayer Healthcare (F), Bayer Healthcare (C), Bioeq/Formycon (F), Bioeq/Formycon (C), Boehringer-Ingelheim (C), CenterVue (F), Ellex (R), Geuder (C), Grayburg Vision (C), Grayburg Vision (R), Heidelberg Engineering (F), LinBioscience (C), NightStarX (F), Novartis (F), Optos (F), Oxurion (C), Pixium Vision (F), Roche/Genentech (F), Roche/Genentech (C), Stealth BioTherapeutics (C), Zeiss (F);
Monika Fleckenstein, Alcon/Novartis (F), Alcon/Novartis (C), Bayer Healthcare (F), Bayer Healthcare (R), Carl Zeiss Meditec (F), CenterVue (F), Genentech (F), Genentech (R), Genentech (C), Heidelberg Engineering (F), Heidelberg Engineering (R), Optos (F), US20140303013 (P)